In A Tighter VC Environment, Biopharmas Need To Get Valuation Right
In the News
9.1.22 | Life Science Leader
Berdon Partner and Leader of the Firm’s Technology and Life Sciences Practice, Jeffrey Kovacs, authored an article that was featured in Life Science Leader. The piece focused on the increased importance of valuations, including the pitfalls of getting them wrong, why you should always evaluate the growth stage of a company when applying a valuation method, and how solid research can give investors confidence to provide funding.
To read the full story, click here.